{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:17:42Z","timestamp":1767835062748,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jhep.2010.01.028","type":"journal-article","created":{"date-parts":[[2010,3,17]],"date-time":"2010-03-17T09:13:05Z","timestamp":1268817185000},"page":"827-831","source":"Crossref","is-referenced-by-count":79,"title":["Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents"],"prefix":"10.1016","volume":"52","author":[{"given":"Etienne M.","family":"Sokal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Bourgois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"St\u00e9phenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Themis","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilda","family":"Porta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dace","family":"Gardovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Fischler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2010.01.028_bib1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/497141","article-title":"Chronic hepatitis C in childhood: an 18-year experience","volume":"41","author":"Iorio","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.01.028_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.mpg.0000228117.52229.32","article-title":"Hepatitis C in children: quaternary referral center perspective","volume":"43","author":"Rumbo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2010.01.028_bib3","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1053\/j.gastro.2008.02.082","article-title":"Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease","volume":"134","author":"Bortolotti","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2010.01.028_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1572-0241.2003.07293.x","article-title":"Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?","volume":"98","author":"Guido","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2010.01.028_bib5","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.22094","article-title":"Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial","volume":"47","author":"Goodman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MPG.0b013e318185998f","article-title":"Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes","volume":"48","author":"Rodrigue","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2010.01.028_bib7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/00006454-199710000-00016","article-title":"Side effects of alfa-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis","volume":"16","author":"Iorio","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jhep.2010.01.028_bib8","first-page":"226","article-title":"Health-related quality of life in children with hepatitis C acquired in the first year of life","volume":"23","author":"Nydegger","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0022-3476(98)70273-2","article-title":"Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children","volume":"133","author":"Bortolotti","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2010.01.028_bib10_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/hep.510260711","article-title":"Epidemiology of hepatitis C","volume":"26","author":"Alter","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib10_2","first-page":"4881","article-title":"Hepatitis C virus infection","volume":"101","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhep.2010.01.028_bib11","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1182\/blood-2001-12-0192","article-title":"Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C","volume":"99","author":"Minola","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2010.01.028_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep.20030","article-title":"Long-term outcome (35 years) of hepatitis C after acquisition of infection through minitransfusions of blood given at birth","volume":"39","author":"Casiraghi","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1086\/345908","article-title":"Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children","volume":"36","author":"Jara","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2010.01.028_bib14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jpeds.2005.10.031","article-title":"The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period","volume":"148","author":"Jhaveri","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jhep.2010.01.028_bib15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2010.01.028_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.510240405","article-title":"Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration","volume":"24","author":"Poynard","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib17","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1002\/hep.510260715","article-title":"Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials","volume":"26","author":"Carithers","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00005176-200201000-00013","article-title":"An analysis of published trials of interferon monotherapy in children with chronic hepatitis C","volume":"34","author":"Jacobson","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2010.01.028_bib20","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/jhep.2002.36495","article-title":"Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C","volume":"36","author":"Wirth","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1053\/jhep.2001.21747","article-title":"Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C","volume":"33","author":"Reddy","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/jhep.2001.26371","article-title":"A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C","volume":"34","author":"Lindsay","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib23","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"Manns","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2010.01.028_bib24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/hep.20661","article-title":"Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C","volume":"41","author":"Wirth","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2010.01.028_bib25","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/01.mpg.0000235974.67496.e6","article-title":"Safety, efficacy and pharmacokinetics of peginterferon \u03b12a (40 Kd) in children with chronic hepatitis C","volume":"43","author":"Schwarz","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jhep.2010.01.028_bib26","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/hep.20884","article-title":"Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics","volume":"42","author":"Gonz\u00e1lez-Peralta","year":"2005","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827810001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T14:55:34Z","timestamp":1544626534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827810001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0168827810001017"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2010.01.028","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}